Graft versus host disease Trials in Atlanta, United States
Conditions / Graft versus host disease / Atlanta, United States
Graft versus host disease is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00366145 | Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE3 |
| NCT00382109 | Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission | COMPLETED | PHASE3 |
| NCT00031824 | Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease | COMPLETED | PHASE3 |
| NCT03842696 | Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT00003056 | Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation | TERMINATED | PHASE3 |
| NCT02877082 | Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients | TERMINATED | PHASE2 |
| NCT05263999 | A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) | TERMINATED | PHASE3 |
| NCT03339297 | An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) | COMPLETED | PHASE2 |
| NCT00562497 | Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE3 |
| NCT01002742 | Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) | COMPLETED | PHASE3 |